Interferences in immunoassay.
- 1 May 2004
- journal article
- Vol. 25 (2), 105-20
Abstract
Substances that alter the measurable concentration of the analyte or alter antibody binding can potentially result in immunoassay interference. Interfering, endogenous substances that are natural, polyreactive antibodies or autoantibodies (heterophiles), or human anti-animal antibodies together with other unsuspected binding proteins that are unique to the individual, can interfere with the reaction between analyte and reagent antibodies in immunoassay. Lipaemia, cross-reactivity, and exogenous interferences due to pre-analytical variation, matrix and equipment reaction also affect immunoassay. Interfering substances may lead to falsely elevated or falsely low analyte concentration in one or more assay systems depending on the site of the interference in the reaction and possibly result in discordant results for other analytes. The prevalence of interference is generally low in assays containing blocking agents that neutralise or inhibit the interference but is often higher in new, untested immunoassays. A wide range of analytes measured by immunoassay including hormones, tumour markers, drugs, cardiac troponin and microbial serology may be affected. Interference in immunoassay may lead to the misinterpretation of a patient's results by the laboratory and the wrong course of treatment being given by the physician. Laboratories should put processes in place to detect, test and report suspected interferences. It is equally important that physicians communicate any clinical suspicion of discordance between the clinical and the laboratory data to the laboratory. The detection of interference may require the use of an alternate assay or additional measurements, before and after treatment with additional blocking reagent, or following dilution of the sample in non-immune serum. It is imperative that laboratories inform physicians of the follow-up procedure and report on the presence of any interference. The establishment of on-going laboratory-physician contact is essential to the continuing awareness of wrong patient results due to interference.This publication has 95 references indexed in Scilit:
- Negative Thyrotropin Assay Interference Associated with an IgGκ ParaproteinClinical Chemistry, 2003
- Wrong biochemistry resultsBMJ, 2001
- Comparative Multicentre Study of a Panel of Thyroid Tests Using Different Automated Immunoassay Platforms and Specimens at High Risk of Antibody Interferencecclm, 2000
- The presence of rheumatoid factor in sera from anti-HCV positive blood donors interferes with the detection of HCV-specific IgMJournal of Hepatology, 1996
- High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomasClinical Endocrinology, 1996
- Reducing interference from heterophilic antibodies in a two-site immunoassay for carcinoembryonic antigen (CEA) by using a human/mouse chimeric antibody to CEA as the tracerJournal of Immunological Methods, 1995
- “Paradoxical” GH Suppression by Secretagogues in Acromegaly?Hormone and Metabolic Research, 1993
- Value of Human Chorionic Gonadotropin Measurements in Blood as a Pregnancy Test in Women on Maintenance HemodialysisNephron, 1985
- CIRCULATING ANTIBODIES TO OVINE AND BOVINE IMMUNOGLOBULIN IN HEALTHY SUBJECTS: A HAZARD FOR IMMUNOASSAYSThe Lancet, 1980
- SPECIFICITY OF THE DIRECT SOLID-PHASE RADIOIMMUNOASSAY FOR DETECTION OF HEPATITIS-B ANTIGENThe Lancet, 1973